Copyright West LLC. Minimum 15 minutes delayed.

Investors & Media


Langer photo

Dennis H. Langer, M.D., J.D.

Director, Dicerna Pharmaceuticals

Dennis H. Langer, M.D., J.D. has served as a member of the Dicerna board of directors since November 2007. Previously, he was chairman of the board of directors and chief executive officer of AdvanDx, Inc., from January 2013 to August 2014.


Dr. Langer has been a clinical professor in the Department of Psychiatry at Georgetown University School of Medicine since September 2003. From August 2005 to May 2010, he served as managing partner of Phoenix IP Ventures, LLC. From January 2004 to July 2005, he served as president, North America of Dr. Reddy’s Laboratories, Inc. Dr. Langer held several positions at GlaxoSmithKline plc and its predecessor, SmithKline Beecham, from September 1994 through January 2004, culminating with the title of senior vice president of research and development. 


Dr. Langer currently serves on the boards of directors of Myriad Genetics, Inc., Pernix Therapeutics Holdings, Inc. and Alzheon, Inc. He previously served on the boards of directors of Auxilium Pharmaceuticals, Inc., Cytogen Corporation, Delcath Systems, Inc., Myrexis, Inc., Pharmacopeia, Inc., and Sirna Therapeutics, Inc.


Dr. Langer received a J.D. from Harvard Law School, an M.D. from Georgetown University School of Medicine, and a B.A. in biology from Columbia University.